IFN-α significantly inhibited glioma cell viability (Figure 5(b)), migratory ability as revealed by the wound healing assay (Figure 5(c)), and invasive ability as revealed by the Transwell assay (Figure 5(d)); after overexpressing CYBRD1, IFN-α-repressed cell viability, migration, and invasion were reversed (Figures 5(b)–5(d)). The gene discussed is IFNA1; the disease is glioma.